Percutaneous transluminal coronary angioplasty (PTCA): long-term outcome and aeromedical implications.
Moorman DL, Kruyer WB, Jackson WG.
Aviat Space Environ Med. 1996 Oct;67(10):990-6.
Percutaneous transluminal coronary angioplasty.
Vlietstra RE, Holmes DR Jr.
J Card Surg. 1988 Mar;3(1):53-66. doi: 10.1111/j.1540-8191.1988.tb00217.x.
The Mechanism of Balloon Impact in Percutaneous Transluminal Coronary Angioplasty in Eccentric Coronary Artery Narrowings.
Saner H, Saner B, Meier B.
Am J Cardiol. 2021 May 1;146:128-131. doi: 10.1016/j.amjcard.2021.01.031. Epub 2021 Feb 3.
Indication for percutaneous coronary angioplasty.
Ghanie A.
Acta Med Indones. 2009 Jul;41(3):159-65.
Percutaneous transluminal coronary angioplasty in hypothyroidism.
Sherman SI, Ladenson PW.
Am J Med. 1991 Mar;90(3):367-70.
Percutaneous coronary intervention.
Jones I, Goode I.
Nurs Times. 2003 Jul 8-14;99(27):46-7.
Spatial analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) in Austria.
Strauss R, Pfeifer C, Ulmer H, Mühlberger V, Pfeiffer KP.
Eur J Epidemiol. 1999 May;15(5):451-9. doi: 10.1023/a:1007577516433.
[Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA].
Warzée F, Legrand V, Scheen AJ.
Rev Med Liege. 2004 Oct;59(10):584-90.
Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review.
Polisena J, Forster AJ, Cimon K, Rabb D.
Syst Rev. 2013 Oct 10;2:94. doi: 10.1186/2046-4053-2-94.
Patient care after percutaneous transluminal coronary angioplasty.
Reynolds S, Waterhouse K, Miller KH.
Nurs Manage. 2001 Sep;32(9):51-4, 56. doi: 10.1097/00006247-200109000-00022.
